Browsing by Subject "(DAA) drug, daclatasvir, treat chronic hepatitis C virus (HCV), active pharmaceutical ingredient (API), Reversed-phase RP-HPLC technique"

Now showing items 1-1 of 1

Validation of a Cost-Effective RP-HPLC Method for Quantitative Investigation of Daclatasvir Dihydrochloride in Pharmaceutical Formulations

Sarfraz, Sadaf; Saeed, Muhammad; Javed, Mohsin; Hussain, Nadia; Iqbal, Shahid; Amin, Shahid; Bahadur, Ali; Jawhari, Ahmed Hussain; Althobiti, Randa A.; Alzahrani, Eman; Farouk, Abd-Elaziem; Aljazzar, Samar O.; Elkaeed, Eslam B. (Hindawi Limited, 2023)

A well-known direct-acting antiviral (DAA) drug called daclatasvir may be used to treat chronic hepatitis C virus (HCV) infection. Herein, we reported a selective, precise, and a cost-effective analytical method for the ...